Endoscopy News and Research

RSS

Olympus America introduces new V-System for ERCP procedure

Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.

From Evident Corporation - Life Sciences 10 Aug 2010

Select Medical teams up with Baylor, joint venture to provide quality health care

Baylor Health Care System and Select Medical Corporation announced today a proposed partnership between Baylor Institute for Rehabilitation and a wholly-owned subsidiary of Select that is designed to create a regional rehabilitation network to serve the Dallas-Fort Worth metroplex. This joint venture is subject to governmental approvals and it is anticipated that the joint venture will be approved and finalized within the normal process for governmental review.

6 Aug 2010

Split-dosage method effective for bowel cleansing before colonoscopy: Study

A new study from researchers in Italy has found that a split-dosage schedule of bowel (colon) preparation is the most effective method for bowel cleansing before colonoscopy. Colonoscopies performed within six to eight hours of the end of preparation were associated with significantly better cleansing than those performed more than eight hours after the end of preparation. Two different types of bowel cleansing products were also assessed and researchers found that low-volume polyethylene glycol (PEG) plus ascorbic acid was as effective as high-volume PEG-electrolyte solution, but has superior palatability (or taste). This is the first study to demonstrate that the advantage of split-dosage intake is also true for low-volume bowel cleansing solutions.

6 Aug 2010

Accellent net sales increase 2.6% to $127.1M in second-quarter 2010

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal second quarter ended June 30, 2010.

6 Aug 2010

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Repligen Corporation today reported results for the first quarter of fiscal year 2011, ended June 30, 2010. Total revenue for the first quarter was $7,010,000 compared to total revenue of $5,061,000 for the first quarter of fiscal year 2010, an increase of $1,949,000 or 39%. Bioprocessing product revenue for the first quarter was $4,269,000 compared to $2,473,000 for the first quarter of fiscal 2010, an increase of $1,796,000 or 73%.

5 Aug 2010

SCA enters into joint venture with West Coast Endoscopy Center to provide management solutions

Surgical Care Affiliates (SCA), one of the country's largest providers of outpatient surgical services, announced today it has entered into a joint venture arrangement with West Coast Endoscopy Center in Clearwater, Florida to partner in the operation of the center.

4 Aug 2010

New trend in management of post-liver transplantation biliary strictures

Endoscopic intervention has emerged to become the first line treatment for benign biliary strictures following liver transplantation. The current endoscopic approach involves repetitive dilatation of the stricture and placement of multiple large-diameter parallel plastic stents with frequent stent exchange to prevent biliary infection.

3 Aug 2010

Surgeons continue to advance minimally-invasive surgery for kidney cancer patients

Surgeons at the University of California, San Diego School of Medicine continue to advance minimally-invasive surgery for cancer patients by reducing the number of abdominal incisions from approximately six to a single small incision.

30 Jul 2010

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

NDS Surgical Imaging (NDSsi) today launched its next-generation visualization and informatics platform—the ConnectOR G2—with production units now shipping to customers. Based on the NDSsi technology vision of Medical Visualization Informatics (MVI), ConnectOR G2 medical-grade products are leading the industry in procedural efficacy by offering the unique ability to connect the realms of PACS imaging, surgical video and medical informatics.

29 Jul 2010

Reusing syringes in anesthesia leads to viral transmission: Study

Hepatitis B virus and hepatitis C virus can be transmitted during intravenous administration of anesthesia, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute. In this study, doctors found that anesthesia contamination - not endoscopy contamination - was the cause of infection.

23 Jul 2010

Boston Scientific second-quarter net sales decrease 7% to $1.928 billion

Boston Scientific Corporation today announced financial results for the second quarter ended June 30, 2010, as well as guidance for net sales and earnings per share (EPS) for the third quarter and full year 2010.

22 Jul 2010

ASP EVOTECH Endoscope Cleaner and Reprocessor technology superior to manual cleaning: Study

Advanced Sterilization Products (ASP) announced today newly published data showing the ASP EVOTECH® Endoscope Cleaner and Reprocessor (ECR) provides an automated approach superior to the manual cleaning required when using traditional AERs. Published in the July issue of Biomed Central, the combination clinical-use and simulated-use study was led by Michelle Alfa, Ph.D., FCCM, Medical Director, Microbiology Discipline Diagnostic Services of Manitoba (DSM) St. Boniface General Hospital Site.

22 Jul 2010

EndoChoice moves corporate headquarters to new 30,000 square foot location in Alpharetta, Georgia

EndoChoice, Inc. today announced that it has moved its corporate headquarters to a new location in Alpharetta, Georgia. The new 30,000 square foot corporate headquarters is three times larger than its previous facility, and features a state-of-the-art GI anatomic pathology laboratory.

21 Jul 2010

ARUP announces new version of Septin 9 methylated DNA test

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.

20 Jul 2010

BARRX Medical closes $15 million Series D financing

BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.

14 Jul 2010

BioImagene licenses Olympus patents in digital pathology, virtual microscopy

Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with BioImagene, Inc. of Sunnyvale, California, allowing BioImagene to access an extensive portfolio of Olympus patents in the field of digital pathology and virtual microscopy. This is the most recent of several licenses that Olympus has granted for the technologies, which are considered critical for developing future digital imaging and data handling systems for pathology.

From Evident Corporation - Life Sciences 12 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.

9 Jul 2010

NOSCAR completes first NOTES transoral and transvaginal gallbladder removal in U.S. human trial

The Natural Orifice Surgery Consortium for Assessment and Research- (NOSCAR-), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announces the completion of the first transoral and transvaginal cholecystectomies (gallbladder removal) using Natural Orifice Translumenal Endoscopic Surgery- (NOTES-) in a multicenter human trial in the United States.

From Evident Corporation - Life Sciences 8 Jul 2010

Landmark study compares oral and transvaginal NOTES to traditional laparoscopy

As part of the only U.S. prospective multicenter clinical trial to compare natural orifice translumenal endoscopic surgery to laparoscopy, surgeons at the University of California, San Diego School of Medicine have performed the trial's first oral gallbladder removal. This landmark study will evaluate whether or not NOTES is safe and as effective as traditional laparoscopic surgery.

8 Jul 2010

Endoscopy News and Research

Olympus America introduces new V-System for ERCP procedure

Select Medical teams up with Baylor, joint venture to provide quality health care

Split-dosage method effective for bowel cleansing before colonoscopy: Study

Accellent net sales increase 2.6% to $127.1M in second-quarter 2010

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

SCA enters into joint venture with West Coast Endoscopy Center to provide management solutions

New trend in management of post-liver transplantation biliary strictures

Surgeons continue to advance minimally-invasive surgery for kidney cancer patients

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

Reusing syringes in anesthesia leads to viral transmission: Study

Boston Scientific second-quarter net sales decrease 7% to $1.928 billion

ASP EVOTECH Endoscope Cleaner and Reprocessor technology superior to manual cleaning: Study

EndoChoice moves corporate headquarters to new 30,000 square foot location in Alpharetta, Georgia

ARUP announces new version of Septin 9 methylated DNA test

BARRX Medical closes $15 million Series D financing

BioImagene licenses Olympus patents in digital pathology, virtual microscopy

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

NOSCAR completes first NOTES transoral and transvaginal gallbladder removal in U.S. human trial

Landmark study compares oral and transvaginal NOTES to traditional laparoscopy

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News